REPLIMUNE GROUP INC (REPL) is drawing unusual attention today. Our newswire has captured 1 story on REPL across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 28/100).
REPLIMUNE GROUP INC stock is moving lower today, falling as much as 25% from its opening price of $9.85 to a session low of $7.37. The decline follows a recent earnings report that missed estimates and ongoing bearish sentiment. The stock is trading at $8.10 as of the latest update with a volume of 1.5 million shares, which is above the 3-month average.
Replimune Group reported Q4 earnings per share of $(0.76), missing the consensus estimate of $(0.71). This result contributed to the stock's sharp intraday decline. Wedbush recently maintained a Neutral rating on the stock but raised its price target to $9, indicating limited upside. The company remains unprofitable with a trailing twelve-month EPS of -3.38 and a market capitalization of $814.5 million. The stock has also seen a recent insider sale, with Chief Commercial Officer Christopher Sarchi selling shares on June 1, 2026.
The stock opened with a small 1.5% gap up but quickly reversed direction. It has traded in a wide range from $9.85 to $7.37, reflecting heightened volatility. Volume has reached 1.5 million shares, or 0.2 times the 3-month average, suggesting increased participation. The 30-day average sentiment score is 49 out of 100, while the 7-day score has dropped to 43, signaling a deteriorating outlook. The stock is currently trading within its 52-week range of $1.50 to $12.50, though it has moved significantly from its recent high.
The stock is currently without an upcoming earnings date. Investors should monitor the breadth of coverage and any further analyst activity for potential shifts in sentiment.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
Wall Street now views the path to clearance for RP1 as increasingly uncertain following two prior rejections.
REPLIMUNE GROUP INC (REPL) is drawing unusual attention today. Our newswire has captured 1 story on REPL across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 28/100). The most recent driver: "REPL Stock Clocks Worst Day In Over 3 Months — New FDA Documents Leave Wall Street Awaiting Another Rejection For Cancer Drug" (Stocktwits News).
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of REPL coverage reads 28/100 over 1 stories; treat it as a research signal and do your own diligence.
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More on REPL: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier REPL move explainers: 2026-07-27